Clincosm LogoSign in Get a demo

solid tumor, adult

Showing 51 - 75 of 199
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Adult Trial in United States (Decoy20)

Recruiting
  • Solid Tumor, Adult
  • Los Angeles, California
  • +4 more
Dec 6, 2022

Solid Tumor, Adult Trial in Chisinau, Madrid, Pamplona (GEN1056)

Recruiting
  • Solid Tumor, Adult
  • GEN1056
  • Chisinau, Moldova, Republic of
  • +2 more
Dec 9, 2022

Universal Germline Testing in the Community

Recruiting
  • Cancer
  • +2 more
  • Invitae's 84 gene multi-cancer panel.
  • Rock Hill, South Carolina
    Carolina Blood and Cancer Care Associates, PA'
Dec 5, 2022

Solid Tumor, Solid Tumor, Adult Trial (Sargramostim, Ipilimumab-containing therapy)

Suspended
  • Solid Tumor
  • Solid Tumor, Adult
  • Sargramostim
  • Ipilimumab-containing therapy
  • Lexington, Massachusetts
    Partner Therapeutics - No Currently Active Sites
Nov 30, 2022

Solid Tumor, Adult, EphA2 Overexpression, KRAS G12V Trial in Beijing (KRAS-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

Recruiting
  • Solid Tumor, Adult
  • +4 more
  • KRAS-EphA-2-CAR-DC
  • +3 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinsese PLA Gereral Hospital
Nov 29, 2022

Solid Tumor, Adult, Lymphoma, EphA2 Overexpression Trial in Beijing (TP53-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

Recruiting
  • Solid Tumor, Adult
  • +6 more
  • TP53-EphA-2-CAR-DC
  • +3 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinsese PLA Gereral Hospital
Nov 29, 2022

Solid Tumor, Adult Trial in Wuxi (177Lu-B5-IgG4)

Not yet recruiting
  • Solid Tumor, Adult
  • Wuxi, Jiangsu, China
    Affiliated Hospital of Jiangnan University
Nov 20, 2022

Solid Tumor, Adult Trial in Worldwide (ASTX029)

Recruiting
  • Solid Tumor, Adult
  • Duarte, California
  • +26 more
Nov 18, 2022

Solid Tumor, Adult Trial in Miami (Pembrolizumab 200 mg Q3W)

Active, not recruiting
  • Solid Tumor, Adult
  • Pembrolizumab 200 mg Q3W
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Nov 18, 2022

Solid Tumor, Adult Trial in United States (eFT226, Sotorasib, Fulvestrant)

Recruiting
  • Solid Tumor, Adult
  • Los Angeles, California
  • +11 more
Nov 15, 2022

Solid Tumor, Adult, Acute Myeloid Leukemia, MDS Trial in India (AUR103)

Recruiting
  • Solid Tumor, Adult
  • +3 more
  • Surat, Gujarat, India
  • +5 more
Oct 31, 2022

Advanced Solid Tumor, Unresectable Solid Tumor, Melanoma Trial in Australia, Canada, United States (MDNA11 Monotherapy, MDNA11

Recruiting
  • Advanced Solid Tumor
  • +24 more
  • MDNA11 Monotherapy
  • MDNA11 in combination with checkpoint inhibitor
  • Santa Monica, California
  • +7 more
Nov 1, 2022

Solid Tumor, Adult Trial in Kansas City, Providence (DF9001, Nivolumab)

Not yet recruiting
  • Solid Tumor, Adult
  • Kansas City, Missouri
  • +1 more
Oct 24, 2022

Solid Tumor, Adult Trial in Korea, Republic of, United States (TTX-030, budigalimab and mFOLFOX6, TTX-030, budigalimab and

Active, not recruiting
  • Solid Tumor, Adult
  • TTX-030, budigalimab and mFOLFOX6
  • +7 more
  • Scottsdale, Arizona
  • +31 more
Oct 18, 2022

Solid Tumor, Adult Trial in United States (SM08502)

Active, not recruiting
  • Solid Tumor, Adult
  • Scottsdale, Arizona
  • +18 more
Oct 17, 2022

Solid Tumor, Adult Trial in Guangzhou (AK112)

Active, not recruiting
  • Solid Tumor, Adult
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 8, 2022

Solid Tumor, Adult, Hematopoietic/Lymphoid Cancer Trial in Worldwide (IV ICT01)

Recruiting
  • Solid Tumor, Adult
  • Hematopoietic/Lymphoid Cancer
  • IV ICT01
  • New Haven, Connecticut
  • +6 more
Oct 5, 2022

Solid Tumor, Adult Trial in United States (GAd-209-FSP low dose, MVA-209-FSP low dose, GAd-209-FSP high dose)

Recruiting
  • Solid Tumor, Adult
  • GAd-209-FSP low dose
  • +5 more
  • Duarte, California
  • +12 more
Oct 2, 2022

Circulating Tumor Cells in Solid Tumors

Completed
  • Solid Tumor, Adult
  • Observational
  • Chapel Hill, North Carolina
    Radiation Oncology Clinic - UNC Cancer Hospital
Sep 27, 2022

Refractory Cancer, Metastatic Cancer, Recurrent Cancer Trial in Santa Monica (SNK01, Avelumab, Pembrolizumab)

Active, not recruiting
  • Refractory Cancer
  • +6 more
  • SNK01
  • +2 more
  • Santa Monica, California
    Sarcoma Oncology Research Center
Sep 25, 2022

Advanced Solid Tumors, Solid Tumor, Solid Carcinoma Trial (Belzutifan)

Active, not recruiting
  • Advanced Solid Tumors
  • +15 more
  • (no location specified)
Sep 16, 2022

Fluoride-labeled Boronophenylalanine PET Imaging in Patients

Not yet recruiting
  • Solid Tumor, Adult
  • BPA-PET imaging
  • (no location specified)
Sep 12, 2022

Solid Tumor, Adult, Pancreatic Ductal; Adenocarcinoma, Ovarian Serous Adenocarcinoma Trial in United States (ZB131)

Recruiting
  • Solid Tumor, Adult
  • +4 more
  • Phoenix, Arizona
  • +8 more
Aug 31, 2022

Cancer, Solid Tumor, Adult, Cancer Metastatic Trial in San Antonio (INV-1120, Pembrolizumab)

Recruiting
  • Cancer
  • +5 more
  • San Antonio, Texas
  • +1 more
Aug 18, 2022

Solid Tumor, Adult Trial in Australia, New Zealand, United States (BGB-24714, Paclitaxel)

Recruiting
  • Solid Tumor, Adult
  • Santa Rosa Beach, Florida
  • +6 more
Aug 19, 2022